Intas Of India Signs Generics Deal With U.K.'s AstraZeneca For Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
India's Intas Pharmaceutical and AstraZeneca of the United Kingdom have signed a deal for supply of generic drugs to treat cancer